Injectable Drug Delivery Market Disrupted Bi Auto Drug Injecting Devices

The injectable drug delivery market is expected to increase with a CAGR of 16.1% during the forecast period of 2019-2025. By 2025, the market has been evaluated to reach a remarkable size of $49.76 billion.

Hyderabad, India - July 22, 2019 /MarketersMedia/ —

The world is consuming sugar at an alarming rate; high consumption of packaged foods is one of the major reason, which in turn affecting the insulin level in common citizens. Diabetic patients are rising globally that increase the usage of insulin pens for injecting insulin inside the body; a major driver for the growth of global injectable drug delivery market, according to a market size intelligence report published by IndustryARC. According to the analyst of the report, the injectable drug delivery market is expected to increase with a CAGR of 16.1% during the forecast period of 2019-2025. By 2025, the market has been evaluated to reach a remarkable size of $49.76 billion.

The report is titled ‘Injectable Drug Delivery Market: By delivery devices (conventional, self-injection, auto-drug, pen injectors, others); By drug formulations (conventional, novel); By therapeutic areas (auto-immune, hormonal, oncology, others); By geography – Forecast (2019-2025).’ This report has been prepared meticulously by the healthcare analyst who has used statistical information in explaining how the market will experience growth in the upcoming years. The report also covers injectable drug delivery market Size by delivery devices and drug formulations, injectable drug delivery market share by top 5 companies and also the market share by start-ups during the forecast period.

View Full Table of Contents of Injectable Drug Delivery Market:
https://www.industryarc.com/Report/1255/injectable-drug-delivery-market-analysis.html

Injectable Drug Delivery Market: Regional Analysis
The global injectable drug delivery market is dominated by the hospitals, clinics, and patient population in North America with a regional share of 40%. The growth is due to consistent efforts from Centre for Disease Control and Prevention to increase medication frequency and delivery success pertaining to chronic illnesses such as heart diseases, cancer, strokes, and others. Another factor responsible for dominated regional share is the development of micro-needles, a solution for needle-phobic population. Some prominent institutes such as Columbia Technology Ventures, National Institute of Health, and NorthShore University Health System Research Institute have also contributed with their extensive research and development.

Injectable Drug Delivery Market: Recent Developments
• Self Injection Devices:
For ease of access, key market players have disrupted the market with self-injection devices. These devices can be used by patients on their own for injecting medication into their bodies. This helps in reducing the extra cost of healthcare services.

• Auto Drug Injecting Devices:
Auto injector is a new healthcare technology that is used to give a single fixed dose of drugs. These devices have been especially manufactured for the treatment of diseases such as multiple sclerosis and rheumatoid arthritis which require frequent injections.

• Pen Injectors:
This is another new technology in this market which is a multi-dose device in contrast to auto drug injecting devices. These have been prescribed by doctors around the world to the geriatric population for taking medication at home for chronic diseases.

Talk to one of our sales representative about the full report by providing your details in the link below:
https://www.industryarc.com/support.php?id=1255

Injectable Drug Delivery Market: Competitive Landscape
This market has witnessed immense growth in the past decade due to research and development efforts by its key market players. These key companies are Alkermes, Inc., Antares Pharma, Inc., Baxter International, Inc., Becton, Dickinson And Company, Bespak Europe, Ltd., Crossject SA, Elcam Medical, Eli Lilly and Company, Gerresheimer AG, Haselmeier GmbH, Injex Pharma GmbH, Novo Nordisk A/S, Owen Mumford Ltd., Sanofi, Schott AG, SHL Group, Terumo Corporation, Unilife Corporation, Vetter Pharma-Fertigung GmbH, West Pharmaceutical Services Inc., YPSOMED Holding AG, and Zogenix Inc.

Related Reports:

A. Home Healthcare Market
https://www.industryarc.com/Report/102/home-healthcare-products-services-equipment-market.html

About IndustryARC:
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

Contact Info:
Name: Venkat Reddy
Email: Send Email
Organization: IndustryARC
Phone: (+1) 614-588-8538
Website: https://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html

Source URL: https://marketersmedia.com/injectable-drug-delivery-market-disrupted-bi-auto-drug-injecting-devices/88898742

Source: MarketersMedia

Release ID: 88898742

Latest News

Facebook paid contractors to transcribe users' audio clips

Aug 18, 2019

NEW YORK — Facebook has paid contractors to transcribe audio clips from users of its Messenger service, raising privacy concerns for a company with a history of privacy lapses. The practice was, until recently, common in the tech industry. Companies say the practice helps improve their services. But users aren't typically aware that humans and not just computers are reviewing audio. Transcriptions done by humans raise bigger concerns because of the potential of rogue employees or contractors leaking details. The practice at Google emerged after some of its Dutch language audio snippets were leaked. More than 1,000 recordings were obtained...

CBS, Viacom to reunite as media giants bulk up for streaming

Aug 18, 2019

NEW YORK — CBS and Viacom announced a long-anticipated reunion Tuesday, bringing together their networks and the Paramount movie studio as traditional media giants bulk up to challenge streaming companies like Netflix. Viacom CEO Bob Bakish, who will become CEO of the combined company, said the new ViacomCBS will be "one of only a few companies with the breadth and depth of content and reach to shape the future of our industry." Analysts say the reunion will help both companies navigate an ever-competitive streaming landscape. Viacom owns Paramount Pictures and pay TV channels such as Comedy Central, MTV and BET,...

Farms turn to technology amid water warnings in Southwest US

Aug 18, 2019

GREELEY, Colo. — A drone soared over a blazing hot cornfield in northeastern Colorado on a recent morning, snapping images with an infrared camera to help researchers decide how much water they would give the crops the next day. After a brief, snaking flight above the field, the drone landed and the researchers removed a handful of memory cards. Back at their computers, they analyzed the images for signs the corn was stressed from a lack of water. This U.S. Department of Agriculture station outside Greeley and other sites across the Southwest are experimenting with drones, specialized cameras and other...

New Michael Moore-backed doc tackles alternative energy

Aug 18, 2019

LOS ANGELES — What if alternative energy isn't all it's cracked up to be? That's the provocative question explored in the documentary "Planet of the Humans," which is backed and promoted by filmmaker Michael Moore and directed by one of his longtime collaborators. It premiered last week at his Traverse City Film Festival. The film, which does not yet have distribution, is a low-budget but piercing examination of what the filmmakers say are the false promises of the environmental movement and why we're still "addicted" to fossil fuels. Director Jeff Gibbs takes on electric cars, solar panels, windmills, biomass, biofuel,...

Streaming music may make cases like Katy Perry's more common

Aug 18, 2019

LOS ANGELES — To show that Katy Perry and the team that wrote her 2013 hit "Dark Horse" may have heard his song and stole from it, Christian rapper Marcus Gray's primary evidence was that his 2009 song, "Joyful Noise" had plays in the millions on YouTube and Spotify. Plaintiffs in copyright cases like Gray, who won a $2.78 million victory over Perry and her co-writers on Thursday, must prove that the artist who stole from them had a reasonable opportunity to hear a song that was widely disseminated, a principle lawyers simply refer to as "access." But does access...

About Us

Science Tech Today is all about the present with what’s new in the Science and Technology world. “Keep up with today, and don’t be left behind.”

Contact us: sales[at]sciencetechtoday.com

Subscribe Now!